Eli Lilly and Co (NYSE:LLY)
| 340.78 Delayed Data As of 4:00pm ET |  +1.10 / +0.32%Today’s Change | 231.87 Today|||52-Week Range 384.44 | -6.85% Year-to-Date |
Latest LLY News | Press Releases
| A Look at Pharma ETFs Post Q4 Earnings 10:05am / Zacks.com - Paid Partner Content | AbbVie Q4 Preview: What's in Store? Feb 03 / Zacks.com - Paid Partner Content |
| Aull & Monroe Investment Management Corp Buys 1, Sells 4 in 4th Quarter 9:00am / GuruFocus News - Paid Partner Content | Pharma Stock Roundup: MRK, LLY, PFE Q4 Results, J&J's Loss in Talc Lawsuits Feb 03 / Zacks.com - Paid Partner Content |
| Is Eli Lilly Stock a Buy Now? 9:00am / MotleyFool.com - Paid Partner Content | Lilly (LLY) Reports Q4 Earnings: What Key Metrics Have to Say Feb 03 / Zacks.com - Paid Partner Content |
| Top 5 4th Quarter Trades of Column Capital Advisors, LLC Feb 06 / GuruFocus News - Paid Partner Content | Eli Lilly (LLY) Q4 2022 Earnings Call Transcript Feb 02 / MotleyFool.com - Paid Partner Content |
| 1 Company Bucks the Office REIT Trend With Higher Rents and Earnings Feb 06 / MotleyFool.com - Paid Partner Content | Lilly (LLY) Beats on Q4 Earnings, Lags on Sales, Raises '23 View Feb 02 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 339.68 |
| Today’s open | 337.57 |
| Day’s range | 337.57 - 342.79 |
| Volume | 2,289,109 |
| Average volume (3 months) | 2,911,046 |
| Market cap | $314.2B |
Data as of 4:00pm ET, 02/08/2023
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +6.74% |
| Earnings growth (next 5 years) | +23.86% |
| Revenue growth (last year) | +0.79% |
| P/E ratio | 51.4 |
| Price/Sales | 11.60 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRKMerck | +0.97 | +0.92% |
| ABBVAbbVie | -0.55 | -0.38% |
| PFEPfizer | +0.38 | +0.87% |
| NVONovo Nordisk | 0.00 | 0.00% |
Data as of 4:00pm ET, 02/08/2023
Financials
| Next reporting date | April 27, 2023 |
| EPS forecast (this quarter) | $1.72 |
| Annual revenue (last year) | $28.5B |
| Annual profit (last year) | $6.2B |
| Net profit margin | 21.88% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Indianapolis, Indiana |
Forecasts
